MG53 compositions and methods of use

Details MG53 compositions and methods of use MG53 compositions and methods of use

2011-07-19

2011-07-19

Spector, Lorraine (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S001100, C514S001200, C514S009400, C514S021200, C435S069100, C435S069700, C530S350000

Reexamination Certificate

active

07981866

ABSTRACT:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

REFERENCES:
patent: 6943241 (2005-09-01), Isogai et al.
patent: 1 440 891 (2004-07-01), None
K.M. Short et al., “Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding”, Journal of Biological Chemistry 281(13):8970-8980, Mar. 31, 2006.
International Search Reportfor PCT/US2007/015815.
Supplementary European Search Report and Opinionfor: App. No. EP 07 86 7154.2-1212 / 2037737; PCT/US2007/015815.

Affiliated with

Also associated with

Rating

MG53 compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MG53 compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MG53 compositions and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2741463